Fig. 1From: Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyKaplan-Meier curve of continued CR success rate. Patients who did not sustain a CR across cycles 1–4 were considered treatment failures. CR, complete response (no emesis, and no use of rescue medication)Back to article page